← Eichor
Study identifier: NCT05388032 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Sodium Lowering Vascular Effects Trial

Condition: Endothelial Dysfunction · Vascular Stiffness · Left Ventricular Hypertrophy  ·  Sponsor: Tulane University

PhaseNA
Planned participants256
Who can joinAll sexes, 40 Years to no upper limit
Healthy volunteersNo

About this study

The proposed mechanistic trial will test the effect of dietary sodium reduction on cardiac and vascular structure and function in those with elevated blood pressure or hypertension. Findings from this study will fill the knowledge gap on the underlying mechanisms of dietary sodium intake on cardiovascular disease risk in addition to blood pressure and could provide further evidence on sodium reduction for the prevention of cardiovascular disease.

This description comes directly from the study's public registry record.

Talk to the study team

Marigny Bostock, MA, CHES  ·  504-988-4391  ·  mbostock@tulane.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Tulane University Office of Health ResearchNew Orleans, Louisiana, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05388032